These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3967090)

  • 41. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
    Heger A; Grunert T; Schulz P; Josic D; Buchacher A
    Thromb Res; 2002 Apr; 106(2):157-64. PubMed ID: 12182916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
    Kurdowska A; Koj A; Jaśkowska M
    Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation.
    de Roux N; Chadeuf G; Molho-Sabatier P; Plouin PF; Aiach M
    Br J Haematol; 1990 Jun; 75(2):222-7. PubMed ID: 2372510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect.
    De Stefano V; Leone G; De Carolis MP; Ferrelli R; De Carolis S; Pagano L; Tortorolo G; Bizzi B
    Thromb Haemost; 1987 Jun; 57(3):329-31. PubMed ID: 3660333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inherited deficiency of antithrombin III in an Italian kindred.
    Tripodi A; Boyer C; Canciani MT; D'Angelo A; Mannucci PM
    Ric Clin Lab; 1980; 10(3):521-9. PubMed ID: 6775364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule.
    Ambruso DR; Leonard BD; Bies RD; Jacobson L; Hathaway WE; Reeve EB
    Blood; 1982 Jul; 60(1):78-83. PubMed ID: 7082848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An abnormal plasma antithrombin with no apparent affinity for heparin.
    Chasse JF; Esnard F; Guitton JD; Mouray H; Perigois F; Fauconneau G; Gauthier F
    Thromb Res; 1984 May; 34(4):297-302. PubMed ID: 6204398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the biological activity of antithrombin III in patients with hepatic cirrhosis.
    Matsuo T; Matsuo C; Matsuo O
    Clin Chim Acta; 1984 Jul; 140(2):125-32. PubMed ID: 6467606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis.
    Tran TH; Bounameaux H; Bondeli C; Honkanen H; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):87-91. PubMed ID: 7455996
    [No Abstract]   [Full Text] [Related]  

  • 52. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.
    Owen MC; Borg JY; Soria C; Soria J; Caen J; Carrell RW
    Blood; 1987 May; 69(5):1275-9. PubMed ID: 3567355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
    Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
    J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency.
    Wolf M; Boyer-Neumann C; Molho-Sabatier P; Neumann C; Meyer D; Larrieu MJ
    Thromb Haemost; 1990 Apr; 63(2):215-9. PubMed ID: 2363123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC; Beresford CH; Carrell RW
    FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin.
    Lindo VS; Kakkar VV; Learmonth M; Melissari E; Zappacosta F; Panico M; Morris HR
    Br J Haematol; 1995 Mar; 89(3):589-601. PubMed ID: 7734359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Isolation and characteristics of antithrombin III from human plasma].
    Markova OA; Kalashnikov VV; Khvatov VB
    Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of congenital antithrombin III deficiency with concentrates.
    Mannucci PM; Boyer C; Wolf M; Tripodi A; Larrieu MJ
    Br J Haematol; 1982 Mar; 50(3):531-5. PubMed ID: 7066204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.